Rinciog, C., Watkins, M., Chang, S., Maher, T. M., LeReun, C., Esser, D., & Diamantopoulos, A. (2016). A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK. Pharmacoeconomics.

Rinciog, C., M. Watkins, S. Chang, T. M. Maher, C. LeReun, D. Esser, و A. Diamantopoulos. "A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK." Pharmacoeconomics 2016.

Rinciog, C., et al. "A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK." Pharmacoeconomics 2016.